Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anja Ernst, Bent Jacobsen, Mette Østergaard, Henrik Okkels, Vibeke Andersen, Enrika Dagiliene, Inge S. Pedersen, Niels Thorsgaard, Asbjørn M. Drewes & Henrik B. Krarup. (2007) Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population. Scandinavian Journal of Gastroenterology 42:12, pages 1445-1451.
Read now
Read now
Articles from other publishers (52)
Stefano Kayali, Stefano Fantasia, Federica Gaiani, Lucas Giovanni Cavallaro, Gian Luigi de’Angelis & Luigi Laghi. (2024)
NOD2
and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired
. Inflammatory Bowel Diseases.
Crossref
Crossref
Maria Witte, Johannes Reiner, Karen Bannert, Robert Jaster, Christian Maschmeier, Clemens Schafmayer, Georg Lamprecht & Peggy Berlin. (2021) Ileocolonic Healing After Extended Small Bowel Resection in Mice: NOD2 Deficiency Impairs Anastomotic Healing and Postoperative Outcome. Inflammatory Bowel Diseases 27:9, pages 1503-1512.
Crossref
Crossref
Bram Verstockt, Sare Verstockt & Isabelle Cleynen. 2018. Fibrostenotic Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease
13
38
.
Sanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, Aleksandra Sokic-Milutinovic, Snezana Lukic, Tamara Alempijevic, Branka Zukic, Nikola Kotur, Gordana Nikcevic, Sonja Pavlovic & Dragan Popovic. (2017) Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 29:8, pages 909-915.
Crossref
Crossref
M. Ellen Kuenzig, Jeff Yim, Stephanie Coward, Bertus Eksteen, Cynthia H. Seow, Cheryl Barnabe, Herman W. Barkema, Mark S. Silverberg, Peter L. Lakatos, Paul L. Beck, Richard Fedorak, Levinus A. Dieleman, Karen Madsen, Remo Panaccione, Subrata Ghosh & Gilaad G. Kaplan. (2017) The NOD2 -Smoking Interaction in Crohn's Disease is likely Specific to the 1007 fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study. EBioMedicine 21, pages 188-196.
Crossref
Crossref
Bram Verstockt & Isabelle Cleynen. (2016) Genetic Influences on the Development of Fibrosis in Crohn’s Disease. Frontiers in Medicine 3.
Crossref
Crossref
Dong Chen, Jiang Liu, Hui-Ying Zhao, Yi-Peng Chen, Zun Xiang & Xi Jin. (2016) Plasma long noncoding RNA expression profile identified by microarray in patients with Crohn’s disease. World Journal of Gastroenterology 22:19, pages 4716.
Crossref
Crossref
Javier Martín-de-Carpi, Alejandro Rodríguez, Esther Ramos, Santiago Jiménez, María José Martínez-Gómez & Enrique Medina. (2013) Increasing Incidence of Pediatric Inflammatory Bowel Disease in Spain (1996–2009). Inflammatory Bowel Diseases 19:1, pages 73-80.
Crossref
Crossref
Jeremy Adler, Sujal C Rangwalla, Ben A Dwamena & Peter DR Higgins. (2011) The Prognostic Power of the NOD2 Genotype for Complicated Crohn's Disease: A Meta-Analysis. American Journal of Gastroenterology 106:4, pages 699-712.
Crossref
Crossref
Séverine Vermeire, Dermot P. McGovern, Gert Van Assche & Paul Rutgeerts. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
16
24
.
Ron Shaoul, Amir Karban, Shimon Reif, Batia Weiss, Raanan Shamir, Ada Tamir, Ofir Davidovich, Jonathan Halevi, Esther Leshinsky Silver & Arie Levine. (2008) Disease Behavior in Children with Crohn’s Disease: The Effect of Disease Duration, Ethnicity, Genotype, and Phenotype. Digestive Diseases and Sciences 54:1, pages 142-150.
Crossref
Crossref
Kelly M. Tarrant, Murray L. Barclay, Christopher M. A. Frampton & Richard B. Gearry. (2008) Perianal Disease Predicts Changes in Crohn's Disease Phenotype-Results of a Population-Based Study of Inflammatory Bowel Disease Phenotype. The American Journal of Gastroenterology 103:12, pages 3082-3093.
Crossref
Crossref
Marijana B. Protic, Sonja T. Pavlovic, Daniela Z. Bojic, Miodrag N. Krstic, Zoran A. Radojicic, Dino K. Tarabar, Ana Z. Stevanovic, Teodora Z. Karan Djurasevic, Mina V. Godjevac, Petar V. Svorcan, Branka D. Dapcevic & Njegica Z. Jojic. (2008) CARD15 gene polymorphisms in Serbian patients with Crohnʼs disease: genotype–phenotype analysis. European Journal of Gastroenterology & Hepatology 20:10, pages 978-984.
Crossref
Crossref
Sylke Schneider-Burrus, Daniela Meixner, Wolfram Sterry & Ansgar Lukowsky. (2008) Common NOD2 mutations are rare in patients with inverse acne. Journal of Dermatological Science 52:1, pages 55-57.
Crossref
Crossref
R K Russell, H E Drummond, D C Wilson, N H Anderson, I D R Arnott, J E Van Limbergen, J Satsangi & E R Nimmo. (2008) Detailed assessment of NOD2/CARD15 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesis. Genes & Immunity 9:6, pages 556-560.
Crossref
Crossref
O. Hradsky, M. Lenicek, P. Dusatkova, J. Bronsky, J. Nevoral, V. Valtrova, R. Kotalova, P. Szitanyi, R. Petro, V. Starzykova, M. Bortlik, L. Vitek, M. Lukas & O. Cinek. (2008)
Variants of
CARD15
,
TNFA
and
PTPN22
and susceptibility to Crohn’s disease in the Czech population: high frequency of the
CARD15
1007fs
. Tissue Antigens 71:6, pages 538-547.
Crossref
Crossref
B. Vucelic & S. Cukovic-Cavka. 2008. IBD 2007 — Achievements in Research and Clinical Practice. IBD 2007 — Achievements in Research and Clinical Practice
30
37
.
Judit Bene, Katalin Komlósi, Lili Magyari, Gábor Talián, Krisztina Horváth, Beáta Gasztonyi, Pál Miheller, Mária Figler, Gyula Mózsik, Zsolt Tulassay & Béla Melegh. (2007) Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. British Journal of Nutrition 98:2, pages 345-350.
Crossref
Crossref
Jean-Pierre Hugot, Isabelle Zaccaria, Juleen Cavanaugh, Huiying Yang, Sverine Vermeire, Maarit Lappalainen, Stefan Schreiber, Vito Annese, Derek P Jewell, Elizabeth V Fowler, Steven R Brant, Mark S Silverberg, Judy Cho, John D Rioux, Jack Satsangi & Miles Parkes. (2007) Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People. The American Journal of Gastroenterology 102:6, pages 1259-1267.
Crossref
Crossref
Klaas van der Linde, Patrick P.C. Boor, Jeanine J. Houwing-Duistermaat, Bart J.A. Crusius, Paul J.H. Wilson, Ernst J. Kuipers & Felix W.M. de Rooij. (2007) CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. European Journal of Gastroenterology & Hepatology 19:6, pages 449-459.
Crossref
Crossref
Vera Bianchi, Giovanni Maconi, Sandro Ardizzone, Elisabetta Colombo, Elisa Ferrara, Antonio Russo, Maria Luisa Tenchini & Gabriele Bianchi Porro. (2007) Association of NOD2/CARD15 mutations on Crohn??s disease phenotype in an Italian population. European Journal of Gastroenterology & Hepatology 19:3, pages 217-223.
Crossref
Crossref
Steven R Brant, Ming-Hsi Wang, Patricia Rawsthorne, Michael Sargent, Lisa Wu Datta, Franklin Nouvet, Yin Yao Shugart & Charles N Bernstein. (2007) A Population-Based Case-Control Study of CARD15 and Other Risk Factors in Crohn's Disease and Ulcerative Colitis. The American Journal of Gastroenterology 102:2, pages 313-323.
Crossref
Crossref
M. Cottone, M. C. Renda, A. Mattaliano, L. Oliva, W. Fries, V. Criscuoli, I. Modesto, D. Scimeca, A. Maggio, A. Casà, S. Maisano, F. Mocciaro, A. Sferrazza & A. Orlando. (2006) Incidence of Crohn’s disease and CARD15 mutation in a small township in Sicily. European Journal of Epidemiology 21:12, pages 887-892.
Crossref
Crossref
G. van Assche, S. Vermeire & P. Rutgeerts. 2007. Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation. Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation
48
54
.
Lene Riis, Ida Vind, Severine Vermeire, Frank Wolters, Kostas Katsanos, Patrizia Politi, João Freitas, Ioannis A. Mouzas, Colm OʼMorain, Victor Ruiz-Ochoa, Selwyn Odes, Vibeke Binder, Pia Munkholm, Bjrn Moum, Reinhold Stockbrügger & Ebbe Langholz. (2007) The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflammatory Bowel Diseases 13:1, pages 24-32.
Crossref
Crossref
Patricia Castro-Santos, Lourdes Mozo, Carmen Gutiérrez & Ana Suárez. (2006) TNFα genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type. Clinical Immunology 121:3, pages 305-313.
Crossref
Crossref
L.E. Oostenbrug, I.M. Nolte, E. Oosterom, G. van der Steege, G.J. te Meerman, H.M. van Dullemen, J.P.H. Drenth, D.J. de Jong, K. van der Linde, P.L.M. Jansen & J.H. Kleibeuker. (2006) CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: An association study and pooled analysis. Digestive and Liver Disease 38:11, pages 834-845.
Crossref
Crossref
S. VERMEIRE. (2006) Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 24:s3, pages 2-10.
Crossref
Crossref
Carles De DiegoMariano AlcántaraJulio ValleMaría José Pérez-GruesoConcepción Muñoz-RosasJosé María CarroblesPedro Martínez-Castro. (2006)
Frequency of
CARD15
Polymorphisms in Patients with Crohn's Disease from Toledo, Spain: Genotype–Phenotype Correlation
. Genetic Testing 10:3, pages 178-185.
Crossref
Crossref
Silvija Cukovic-Cavka, Severine Vermeire, Irena Hrstic, Greet Claessens, Sanja Kolacek, Jasminka Jakic-Razumovic, Zeljko Krznaric, Katja Grubelic, Davor Radic, Zrinjka Misak, Oleg Jadresin, Paul Rutgeerts & Boris Vucelic. (2006) NOD2/CARD15 mutations in Croatian patients with Crohn??s disease: prevalence and genotype???phenotype relationship. European Journal of Gastroenterology & Hepatology 18:8, pages 895-899.
Crossref
Crossref
Valentina Medici, Silvia Mascheretti, Peter J P Croucher, Monika Stoll, Jochen Hampe, Jochen Grebe, Giacomo C Sturniolo, Camilla Solberg, Jorgen Jahnsen, Bjorn Moum, Stefan Schreiber & Morten H Vatn. (2006) Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. European Journal of Human Genetics 14:4, pages 459-468.
Crossref
Crossref
Daniel R Gaya, Richard K Russell, Elaine R Nimmo & Jack Satsangi. (2006) New genes in inflammatory bowel disease: lessons for complex diseases?. The Lancet 367:9518, pages 1271-1284.
Crossref
Crossref
Liekele E. Oostenbrug, Hendrik M. van Dullemen, Gerard J. te Meerman, Peter L.M. Jansen & Jan H. Kleibeuker. (2006) Clinical outcome of Crohn??s disease according to the Vienna classification: disease location is a useful predictor of disease course. European Journal of Gastroenterology & Hepatology 18:3, pages 255-261.
Crossref
Crossref
Graham Radford-Smith. (2006) Associations between NOD2/CARD15 genotype and phenotype in Crohn’s disease-Are we there yet. World Journal of Gastroenterology 12:44, pages 7097.
Crossref
Crossref
AS Peña. (2006) Contribution of genetics to a new vision in the understanding of inflammatory bowel disease. World Journal of Gastroenterology 12:30, pages 4784.
Crossref
Crossref
Juan L Mendoza, Elena Urcelay, Raquel Lana, Alfonso Martinez, Carlos Taxonera, Emilio G de la Concha & Manuel Díaz-Rubio. (2006)
Polymorphisms in interleukin-10 gene according to mutations of
NOD2/CARD15
gene and relation to phenotype in Spanish patients with Crohn’s disease
. World Journal of Gastroenterology 12:3, pages 443.
Crossref
Crossref
Elena Urcelay, Juan L Mendoza, Carmen M Martín, Ana Mas, Alfonso Martínez, Carlos Taxonera, Miguel Fernandez-Arquero, Manuel Díaz-Rubio & Emilio G de la Concha. (2006) MDR1 gene: Susceptibility in Spanish Crohnʼs disease and ulcerative colitis patients. Inflammatory Bowel Diseases 12:1, pages 33-37.
Crossref
Crossref
John B. Beckly, Tariq Ahmad & Derek P. Jewell. 2006. Challenges in Inflammatory Bowel Disease. Challenges in Inflammatory Bowel Disease
14
32
.
Francesc Casellas, Josefa Lopez Vivancos, Manuela Sampedro & Juan-Ramon Malagelada. (2005) Relevance of the Phenotypic Characteristics of Crohn's Disease in Patient Perception of Health-Related Quality of Life. The American Journal of Gastroenterology 100:12, pages 2737-2742.
Crossref
Crossref
Séverine Vermeire, Marie Pierik, Tibor Hlavaty, Greet Claessens, Nele van Schuerbeeck, Sofie Joossens, Marc Ferrante, Liesbet Henckaerts, Mirjam Bueno de Mesquita, Robert Vlietinck & Paul Rutgeerts. (2005) Association of Organic Cation Transporter Risk Haplotype With Perianal Penetrating Crohn’s Disease but Not With Susceptibility to IBD. Gastroenterology 129:6, pages 1845-1853.
Crossref
Crossref
S Vermeire & P Rutgeerts. (2005) Current status of genetics research in inflammatory bowel disease. Genes & Immunity 6:8, pages 637-645.
Crossref
Crossref
Richard K Russell, Hazel E Drummond, Elaine E Nimmo, Niall Anderson, Linda Smith, David C Wilson, Peter M Gillett, Paraic McGrogan, Kamal Hassan, Lawrence T Weaver, Michael Bisset, Gamal Mahdi & Jack Satsangi. (2005) Genotype-phenotype Analysis in Childhood-onset Crohnʼs Disease: NOD2/CARD15 Variants Consistently Predict Phenotypic Characteristics of Severe Disease. Inflammatory Bowel Diseases 11:11, pages 955-964.
Crossref
Crossref
J. Halfvarson, F. Bresso, M. D’Amato, G. Järnerot, S. Pettersson & C. Tysk. (2005) CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins. Digestive and Liver Disease 37:10, pages 768-772.
Crossref
Crossref
Juan Luis Mendoza, Raquel Lana, Carlos Taxonera, Cristina Alba, Sonia Izquierdo & Manuel Díaz-Rubio. (2005) Manifestaciones extraintestinales en la enfermedad inflamatoria intestinal: diferencias entre la enfermedad de Crohn y la colitis ulcerosa. Medicina Clínica 125:8, pages 297-300.
Crossref
Crossref
Amir Karban, Oren Atia, Eran Leitersdorf, Azmi Shahbari, Wisam Sbeit, Zvi Ackerman, Rawia Mualem, Arie Levine, Shula Nesher, Rifaat Safadi & Rami Eliakim. (2005) The Relation Between NOD2/CARD15 Mutations and the Prevalence and Phenotypic Heterogeneity of Crohn’s Disease: Lessons from the Israeli Arab Crohn’s Disease Cohort. Digestive Diseases and Sciences 50:9, pages 1692-1697.
Crossref
Crossref
Steven R Brant & Dermot P. B. McGovern. (2005) Nod2, Not Yet.. Inflammatory Bowel Diseases 11:5, pages 507-509.
Crossref
Crossref
Vito Annese, Giovanni Lombardi, Francesco Perri, Renata D'Inca, Sandro Ardizzone, Gabriele Riegler, Stelio Giaccari, Maurizio Vecchi, Fabiana Castiglione, Paolo Gionchetti, Elena Cocchiara, Sergio Vigneri, Anna Latiano, Orazio Palmieri & Angelo Andriulli. (2005) Variants of CARD15 are Associated with an Aggressive Clinical Course of Crohn's Disease-An IG-IBD Study. The American Journal of Gastroenterology 100:1, pages 84-92.
Crossref
Crossref
Yoshitaka Kinouchi, Kenichi Negoro, Sho Takagi, Sciichi Takahashi & Tooru Shimosegawa. (2005) Genotype and phenotype relation in inflammatory bowel disease. Journal of Gastroenterology 40:S16, pages 21-24.
Crossref
Crossref
S. Vermeire. 2005. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice
34
40
.
Michael Economou, Thomas A. Trikalinos, Konstantinos T. Loizou, Epameinondas V. Tsianos & John P.A. Ioannidis. (2004) Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis. The American Journal of Gastroenterology 99:12, pages 2393-2404.
Crossref
Crossref
Francesc Casellas i Jordà. (2004) Inhibidores del factor de necrosis tumoral alfa en la enfermedad inflamatoria intestinal. Medicina Clínica 123:16, pages 627-634.
Crossref
Crossref
J.L. Mendoza Hernández, R. Lana Soto & M. Díaz-Rubio Garcíac. (2004) Importancia de las mutaciones del NOD2/CARD15 en la enfermedad de Crohn. Revista Clínica Española 204:12, pages 642-644.
Crossref
Crossref